<DOC>
	<DOCNO>NCT02222844</DOCNO>
	<brief_summary>The IMPRESS trial aim see whether improved result achieve patient pelvic sigmoid cancer MRI scan prior surgery doctor make appropriate treatment choice . Everyone agrees take part randomly allocate one research team either standard treatment sigmoid cancer , involve CT-imaging chest abdomen / pelvis surgery , undergo standard treatment , plus additional MRI scan , surgery . The additional MRI scan difference approach two arm trial . After image obtain , patient arm discuss Multidisciplinary Team usual . An amendment study 2015 allow patient sigmoid cancer receive MRI local indication enter trial observational patient , new primary endpoint add compare rate high risk feature identify CT MRI scan patient .</brief_summary>
	<brief_title>Improving Radical Treatment Through MRI Evaluation Pelvic Sigmoid Cancers</brief_title>
	<detailed_description>The primary objective IMPRESS Trial compare proportion patient undergoing radical treatment two arm study . Another primary endpoint measure difference detection high risk patient compare CT MRI patient . Secondary outcome measure proportion patient underwent neoadjuvant treatment , quality surgery include free resection margin , perioperative morbidity mortality , permanent defunctioning stoma rate , downstaging , quality life 1 year , 3 year 5 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Sigmoid Neoplasms</mesh_term>
	<criteria>All patient pelvic sigmoid colon ( demonstrate colonoscopy biopsy ) eligible curative treatment ( purpose IMPRESS study , sigmoid tumour must 15cm anal verge ) Less 18 year old Unable consent Consent witheld withdrawn Unable MRI ( e.g . pacemaker , metal implant major viscera , severe claustrophobia ) Allergy contraindication Buscopan , small bowel contrast agent gadolinium ( e.g . glaucoma , small large bowel obstruction , GFR &lt; 30 ) A previous history colorectal cancer Presence irresectable distant metastasis Severe comorbidities prevent application eventual chemo/radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Colon , Sigmoid</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>General Surgery</keyword>
	<keyword>Postoperative Complications</keyword>
</DOC>